Systematic Review of Artificial Intelligence in Acute Respiratory Distress Syndrome for COVID-19 Lung Patients: A Biomedical Imaging Perspective

SARS-CoV-2 has infected over ∼165 million people worldwide causing Acute Respiratory Distress Syndrome (ARDS) and has killed ∼3.4 million people. Artificial Intelligence (AI) has shown to benefit in the biomedical image such as X-ray/Computed Tomography in diagnosis of ARDS, but there are limited AI...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IEEE 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843049/
https://www.ncbi.nlm.nih.gov/pubmed/34379599
http://dx.doi.org/10.1109/JBHI.2021.3103839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843049/
https://www.ncbi.nlm.nih.gov/pubmed/34379599
http://dx.doi.org/10.1109/JBHI.2021.3103839

Ejemplares similares